GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » 1-Year ROIIC %

LifeTech Scientific (HKSE:01302) 1-Year ROIIC % : -29.80% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. LifeTech Scientific's 1-Year ROIIC % for the quarter that ended in Dec. 2023 was -29.80%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for LifeTech Scientific's 1-Year ROIIC % or its related term are showing as below:

HKSE:01302's 1-Year ROIIC % is ranked worse than
65.35% of 834 companies
in the Medical Devices & Instruments industry
Industry Median: -1.69 vs HKSE:01302: -29.80

LifeTech Scientific 1-Year ROIIC % Historical Data

The historical data trend for LifeTech Scientific's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific 1-Year ROIIC % Chart

LifeTech Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 -11.37 -257.56 -1.86 -29.80

LifeTech Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -257.56 -86.14 -1.86 -0.81 -29.80

Competitive Comparison of LifeTech Scientific's 1-Year ROIIC %

For the Medical Devices subindustry, LifeTech Scientific's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's 1-Year ROIIC % falls into.



LifeTech Scientific 1-Year ROIIC % Calculation

LifeTech Scientific's 1-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 197.1724784 (Dec. 2023) - 322.9165741 (Dec. 2022) )/( 3316.14 (Dec. 2023) - 2894.158 (Dec. 2022) )
=-125.7440957/421.982
=-29.80%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


LifeTech Scientific  (HKSE:01302) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


LifeTech Scientific 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeTech Scientific (HKSE:01302) Business Description

Traded in Other Exchanges
Address
No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.
Executives
Xie Yuehui 2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited 2101 Beneficial owner
Hhlr Advisors, Ltd. 2102 Investment manager
Bank Of Communications Trustee Limited 2301 Trustee
Xie Yuehui 2201 Interest of corporation controlled by you
Hhlr Fund, L.p. 2101 Beneficial owner
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

LifeTech Scientific (HKSE:01302) Headlines

No Headlines